Fibulo-ulnar hypoplasia-renal anomalies syndrome

Fibulo-ulnar hypoplasia-renal anomalies syndrome, also known as fibular aplasia or hypoplasia, femoral bowing and poly-, syn-, and oligodactyly (or Fuhrmann syndrome), is an extremely rare congenital malformation syndrome characterized by limb and kidney abnormalities present at birth. The condition primarily affects the skeletal system and the urinary system. Key skeletal features include hypoplasia (underdevelopment) or aplasia (absence) of the fibula and ulna — the outer bones of the lower and upper limbs respectively — along with bowing of the femur, and various digit anomalies including oligodactyly (fewer than normal fingers or toes), syndactyly (fused digits), and polydactyly (extra digits). Renal (kidney) anomalies may also be present, ranging from structural malformations to functional impairment. Additional features may include nail hypoplasia and short stature. This syndrome has been described in only a very small number of families in the medical literature, making it one of the rarest genetic skeletal disorders. The condition is believed to follow an autosomal recessive inheritance pattern, meaning that an affected individual must inherit a disease-causing variant from both parents. Because of its extreme rarity, no specific gene has been definitively identified as causative, and the molecular basis remains poorly understood. There is currently no cure or disease-specific treatment for fibulo-ulnar hypoplasia-renal anomalies syndrome. Management is supportive and symptomatic, typically involving a multidisciplinary team including orthopedic surgeons, nephrologists, and rehabilitation specialists. Orthopedic interventions such as corrective surgery, prosthetics, or bracing may be used to improve limb function and mobility. Kidney anomalies require monitoring and appropriate urological or nephrological management. Genetic counseling is recommended for affected families.

Common questions about Fibulo-ulnar hypoplasia-renal anomalies syndrome